Insomnia Clinical Trial
— YOGiOfficial title:
The Effects of a 4-week Vinyasa Yoga Program on Sleep and Cardiovascular Health in Adults With Insomnia Symptoms: A Randomized Controlled Trial
Verified date | July 2023 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of our study is to examine the effects of a 4-week vinyasa yoga program on sleep-related and cardiovascular outcomes in adults with insomnia symptoms. This study will examine the following aims: To examine the effects of a 4-week vinyasa yoga program compared to a non-active control condition on subjective and objective sleep-related outcomes in adults who report insomnia symptoms. To examine the effects of a 4-week vinyasa yoga program compared to a non-active control on cardiovascular health. To examine the effects of a single session of vinyasa yoga compared to a non-active control condition on sleep- and cardiovascular-related outcomes collected overnight. Researchers will compare the yoga group and the non-active control group to see if there are any improvements in sleep and cardiovascular health.
Status | Completed |
Enrollment | 33 |
Est. completion date | June 26, 2023 |
Est. primary completion date | June 26, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: 1. Insomnia Severity Index (ISI) score = 10 2. Age 18-55 years 3. Insufficiently active defined by the Stanford Leisure-Time Activity Categorical Item responses below public health physical activity guidelines Exclusion Criteria: 1. Self-reported regular vinyasa and/or power yoga practice defined as = 60 minutes/week within the past 3 months 2. Diagnosed medical condition requiring medical clearance defined as a 'yes' response on follow-up questions pertaining to a present medical condition(s) via Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) 3. Physical limitations and/or mobility restriction that would interfere with the ability to perform yoga defined as a 'yes' response on the PAR-Q+; self-reported lack of treatment for a major psychiatric disorder via medical history survey 4. High risk for obstructive sleep apnea defined as score = 5 via STOP-Bang score 5. Self-reported current pregnancy or planning to become pregnant within the next 3 months 6. Overnight shift work defined as regularly working any time between 00:00 and 06:00 am 7. Self-reported current treatment for insomnia via medical history survey 8. Medications that may affect heart rate during exercise via self-report on the medical history survey |
Country | Name | City | State |
---|---|---|---|
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Sleep efficiency | Mean actigraphy-assessed sleep efficiency will be immediately assessed after the initial session of the intervention for 1 night | Immediately after first intervention session (1 night) | |
Other | Total sleep time | Mean actigraphy-assessed total sleep time will be immediately assessed after the initial session of the intervention | Immediately after first intervention session (1 night) | |
Other | Nocturnal root mean square of successive difference between normal heartbeats | Nocturnal root mean square of successive difference between normal heartbeats will be assessed immediately after the first intervention session for 1 night; an increase value indicates better cardiovascular health | Immediately after first intervention session (1 night) | |
Other | Change in acute anxiety symptoms | Acute anxiety symptoms will be measured using the State-Trait Inventory 20-item pre- and post-initial first intervention session | pre- and post-initial intervention session | |
Other | Change in mood | Acute changes in mood will be measured using the Profile of Mood States brief form. This will assess the feelings of tension, depressed mood, energy, fatigue, and total mood disturbances based on how the participant feels right now using a 5-point Likert scale ranging from 0 "not at all" to 4 "extremely | pre- and post-initial intervention session | |
Other | Change in percent body composition | Body composition will be measured using the bio-electrical impedance; a decrease in percentage indicates improved body composition | baseline, post-intervention (4 weeks) | |
Primary | Change in Insomnia Severity Index | Insomnia Severity Index is a 7-item self-report questionnaire that assesses the severity of the nighttime and daytime impact of insomnia symptoms. Each question is rated on a 5-point Likert scale, with a score of 0 indicating 'no problem' and 4 indicating 'very severe'. The total score is obtained by summing the scores of the individual items ranging from 0 to 28; a higher score indicates more severe insomnia symptoms. | Baseline, post-intervention (4 weeks) | |
Primary | Change in nocturnal root mean square of successive difference between normal heartbeats (RMSSD) | Nocturnal root mean square of successive difference between normal heartbeats will be assessed for 1 night with a Polar heart rate monitor strap; an increase indicates better cardiovascular health | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline sleep efficiency at 4 weeks | Actigraphy-assessed sleep efficiency, averaged over 7 nights | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline total sleep time at 4 weeks | Actigraphy-assessed total sleep time, averaged over 7 nights | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline resting systolic blood pressure at 4 weeks | Resting systolic blood pressure will be measured using an automated blood pressure system in the seated position | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline resting heart rate at 4 weeks | Resting heart rate will be measured using a automated blood pressure system in the seated position | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline resting carotid-femoral pulse wave velocity | Pulse wave velocity is a measure of arterial stiffness | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline quality of sleep | Sleep quality will be assessed using a sleep diary on a scale of 'very poor' to 'very good' | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline in Epworth Sleepiness Scale | Daytime sleepiness will be measured using the Epworth Sleepiness Scale (ESS). It is a brief 8-item questionnaire asking individuals to rate the likelihood of falling asleep on a 4-point scale (0 indicating 'would never doze off' and '3' indicating 'high chance of dozing') across eight situations that occur in daily life. The scores are summed for a total score that ranges from 0-24; a score = 10 indicating clinically significant daytime sleepiness. | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline in Ford Insomnia Response to Stress Test | Sleep reactivity, the stress-related vulnerability to experience sleep disturbances under stressful conditions will be measured by the Ford Insomnia Response to Stress Test; higher scores are associated with more sleep difficulties and elevated physiological stress. | Baseline, post-intervention (4 weeks) | |
Secondary | Change from baseline in Patient Health Questionnaire | Depression severity will be measured using the Patient Health Questionnaire which assess depressive symptoms over the past two weeks; a score > 10 indicates moderate severity depression symptoms. | Baseline, post-intervention ( 4 weeks) | |
Secondary | Change from baseline in Generalized Anxiety Disorder-7 Questionnaire | Anxiety severity will be measured using the Generalized Anxiety Disorder Questionnaire which assess symptoms over the past two weeks; a score = 10 detects generalized anxiety disorder. | Baseline, post-intervention (4 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A |